PM
Prosight Management, LP cut its ADCT stake below 5%
Prosight Management, LP reported owning 0.3% of ADC Therapeutics SA (ADCT) (399,900 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.